טוען...
Disease- and treatment-associated acquired glucocorticoid resistance
The development of resistance to glucocorticoids (GCs) in therapeutic regimens poses a major threat. Generally, GC resistance is congenital or acquired over time as a result of disease progression, prolonged GC treatment or, in some cases, both. Essentially, disruptions in the function and/or pool o...
שמור ב:
| הוצא לאור ב: | Endocr Connect |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Bioscientifica Ltd
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6280593/ https://ncbi.nlm.nih.gov/pubmed/30352419 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EC-18-0421 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|